- Previous Close
79.33 - Open
76.55 - Bid --
- Ask --
- Day's Range
74.07 - 76.55 - 52 Week Range
74.07 - 103.95 - Volume
264 - Avg. Volume
934 - Market Cap (intraday)
3.708B - Beta (5Y Monthly) 1.01
- PE Ratio (TTM)
0.04 - EPS (TTM)
19.03 - Earnings Date May 28, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia; and spherical lense, including lenses that correct near and farsightedness in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage to health care professionals and patients worldwide. It offers surgical and office products, including paragard contraceptive intrauterine devices; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
www.coopercos.com16,000
Full Time Employees
October 31
Fiscal Year Ends
--
Sector
--
Industry
Recent News: 0I3I.L
View MorePerformance Overview: 0I3I.L
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 0I3I.L
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 0I3I.L
View MoreValuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
10.57%
Return on Assets (ttm)
3.80%
Return on Equity (ttm)
5.25%
Revenue (ttm)
3.93B
Net Income Avi to Common (ttm)
415.4M
Diluted EPS (ttm)
19.03
Balance Sheet and Cash Flow
Total Cash (mrq)
100.9M
Total Debt/Equity (mrq)
31.25%
Levered Free Cash Flow (ttm)
243M